PPT-Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary

Author : giovanna-bartolotta | Published Date : 2019-11-07

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease The COMPASS Trial Kelley Branch MD MSc on behalf

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Rivaroxaban Plus Aspirin in Patients Wit..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary: Transcript


Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease The COMPASS Trial Kelley Branch MD MSc on behalf of the COMPASS Steering Committee and Investigators. (EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS. PGY2 Cardiology Resident. WakeMed. Health & . Hosptials. Raleigh, NC. Dr. . Ryan Sparks (presenter). Current PGY2 Cardiology Resident at . WakeMed. Coronary Heart Disease. Affects 16 million people. Causes more than 600,000 death annually. Caused by impaired blood flow to the myocardium. Accumulation of atherosclerotic plaque in the coronary arteries usual cause.. Diana R. Phelps. CPC, CPC-I, CEMC. Approved ICD-10-CM Instructor. It keeps ticking!. Define abbreviations and key terms. What . makes the heart work. ICD-10-CM common codes. Cardiac procedures and surgeries. Coronary Artery Disease & Acute Coronary Syndrome Anthony J. Viera, MD, MPH, FAHA Professor and Chair Objectives Describe the appropriate work-up for chest pain based on clinical factors Know the first-line medications for CAD and recognize important side effects and contraindications Tanveer Rab, MD, FACC. Perwaiz M. Meraj, MD, FACC. Starting a Complex Coronary . Intervention Program. Does your hospital have the volume?. Buy in from administration and your colleagues. Is there a will to invest? . Pictorial Presentation. Mike Clark, M.D.. Figure 18.7a. Right. ventricle. Right. coronary. artery. Right. atrium. Right. marginal. artery. Posterior. interventricular. artery. Anterior. interventricular. B . hussam. PhD Clinical pharmacy. Coronary heart disease (CHD), sometimes described . as coronary . artery disease (CAD) or . ischaemic. heart . disease (IHD. ), is a condition in which the vascular supply to . Heart Location. Location of Heart. Enclosed within the . mediastinum. , the medial cavity of the thorax, . extending obliquely. for about 5 inches from the second rib to the fifth intercostal space, rests on the . Sonia Anand, on . behalf of the COMPASS Steering Committee and . Investigators. 17-07-01. August 27, 2017. COMPASS PAD rationale. PAD patients have . widespread atherosclerosis . and increased . risk of . worldwide with age being the . most important . non-modifiable . risk . factor. . Prevalence of CAD in adults under 30 has been estimated to be very low . (Fig. 1. ), . however its true prevalence is unknown.. in Patients with End-stage Renal Disease on Hemodialysis. Sarah Nisivaco. 1. , Brooke Patel. 1. , Kaitlin Grady. 1. , Husam H Balkhy. 1. 1. Department of Surgery, University of Chicago Medicine, Chicago, IL, USA. CVTS. SURGICAL REVASCULARIZATION IN DEPRESSED CARDIAC FUNCTION:. A CHALLENGE. Coronary Artery . Disease:Epidemiology. I. schemic . heart disease . (prevalence 35 . - 40. %). CHD may manifest itself in many presentations:. Rajesh . Tota-Maharaj. , Michael J . Blaha. , . Ron . Blankstein. , . Leslee. J Shaw, . Roger . S Blumenthal, . Matthew . J . Budoff. , . Khurram. . Nasir. .. No disclosures for this presentation.. CrCl. : creatinine clearance, CTO: chronic total occlusion, DAPT: dual antiplatelet therapy, DOAC: direct oral anticoagulant, . eDAN. : electronic discharge advice notification, GFR: glomerular filtration rate, HF: heart failure, INR: international normalised ratio, LHP: Leeds Health Pathways, LTHT: Leeds Teaching Hospitals NHS Trust, LV: left ventricular, MACE: major adverse cardiovascular event, MI: myocardial infarction, NICE: National Institute for Health and Care Excellence, NSTEMI: non-ST segment elevation myocardial infarction, STEMI: ST segment elevation myocardial infarction, OD: once daily, PAD: peripheral arterial disease, P2Y12: platelet receptor for adenosine diphosphate PCI: percutaneous coronary intervention, PPI: proton pump inhibitor, SPC: summary of product characteristics, TIA: transient ischaemic attack..

Download Document

Here is the link to download the presentation.
"Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents